Sri Lanka’s drug pricing reform: balancing affordability with sustainability
Ensuring fair and transparent pharmaceutical pricing was a key promise of Sri Lanka’s ruling government’s election manifesto, and that promise…
Analyst Comment
Top 20 biopharma companies Q3 2025 market cap up 4% despite headwinds
AI breakthrough promises earlier prostate cancer diagnosis
ESMO 2025: Sichuan-Kelun moves in breast cancer ADC space
ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC
A new vision for keratoconus: Epioxa redefines treatment after a decade-long wait
Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing
The threshold debate in Norway
